Beta-cell protection and therapy for latent autoimmune diabetes in adults.

Diabetes care

Volumn 32 Suppl 2, Issue , 2009, Pages

  Cernea, Simona ^a   Buzzetti, Raffaella ^a   Pozzilli, Paolo ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CHAPERONIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; INSULIN; INSULIN ANTIBODY; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; BLOOD; DRUG EFFECT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADULT; AGE OF ONSET; CHAPERONIN 60; DIABETES MELLITUS, TYPE 1; GLUTAMATE DECARBOXYLASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ANTIBODIES; INSULIN-SECRETING CELLS; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 75549089925     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-s317     Document Type: Review

References (52)